Jamsheed Javid

557 total citations
45 papers, 439 citations indexed

About

Jamsheed Javid is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jamsheed Javid has authored 45 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 14 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Jamsheed Javid's work include MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (9 papers) and Cancer-related Molecular Pathways (8 papers). Jamsheed Javid is often cited by papers focused on MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (9 papers) and Cancer-related Molecular Pathways (8 papers). Jamsheed Javid collaborates with scholars based in Saudi Arabia, India and United States. Jamsheed Javid's co-authors include Rashid Mir, Alpana Saxena, Paramita Ray, Mariyam Zuberi, Joydeep Das, Shiekh Tanveer Ahmad, Imadeldin Elfaki, Faisel M. Abuduhier, Suriya Rehman and Abdullatif Taha Babakr and has published in prestigious journals such as Tumor Biology, Medical Oncology and Annals of Translational Medicine.

In The Last Decade

Jamsheed Javid

41 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jamsheed Javid Saudi Arabia 11 305 219 54 35 35 45 439
Xiaojing Jia China 13 262 0.9× 202 0.9× 84 1.6× 41 1.2× 35 1.0× 19 419
Joana Assis Portugal 14 195 0.6× 122 0.6× 100 1.9× 63 1.8× 20 0.6× 30 392
Caifeng Yue China 9 305 1.0× 150 0.7× 113 2.1× 51 1.5× 41 1.2× 20 481
Zheng Gao China 12 247 0.8× 104 0.5× 41 0.8× 26 0.7× 63 1.8× 34 453
He Tian China 13 194 0.6× 94 0.4× 55 1.0× 68 1.9× 50 1.4× 35 363
Yanhui Jiang China 10 277 0.9× 244 1.1× 59 1.1× 33 0.9× 22 0.6× 27 394

Countries citing papers authored by Jamsheed Javid

Since Specialization
Citations

This map shows the geographic impact of Jamsheed Javid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamsheed Javid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamsheed Javid more than expected).

Fields of papers citing papers by Jamsheed Javid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jamsheed Javid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamsheed Javid. The network helps show where Jamsheed Javid may publish in the future.

Co-authorship network of co-authors of Jamsheed Javid

This figure shows the co-authorship network connecting the top 25 collaborators of Jamsheed Javid. A scholar is included among the top collaborators of Jamsheed Javid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jamsheed Javid. Jamsheed Javid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elfaki, Imadeldin, et al.. (2025). Identification of Interactive Genetic Loci Linked to Insulin Resistance in Metabolic Syndrome—An Update. Medicina. 61(1). 83–83. 3 indexed citations
2.
Mir, Rashid, Jamsheed Javid, Mohammad Fahad Ullah, et al.. (2025). Metabolic reprogramming and functional crosstalk within the tumor microenvironment (TME) and A Multi-omics anticancer approach. Medical Oncology. 42(9). 373–373. 1 indexed citations
3.
Javid, Jamsheed, Rashid Mir, Imadeldin Elfaki, et al.. (2024). Dysregulated Vitamin D, CYP2R1, TCF7L2, and CCR5 Δ32 Gene Variations are Associated with Coronary Artery Disease. Discovery Medicine. 36(190). 2287–2287. 1 indexed citations
6.
7.
Mir, Rashid, et al.. (2018). Potential Impact of COMT-rs4680 G > A Gene Polymorphism in Coronary Artery Disease. Journal of Cardiovascular Development and Disease. 5(3). 38–38. 9 indexed citations
8.
Mir, Rashid, et al.. (2017). Optimization of allele specific PCR (AS-PCR) for the early detection of FLT3 (D835Y) mutation in Acute Myeloid Leukemia patients at Tabuk, Saudi Arabia.. International Journal of Advanced Research. 5(1). 817–822. 1 indexed citations
9.
Mir, Rashid, Jamsheed Javid, Mariyam Zuberi, et al.. (2016). The C609T (Pro187Ser) Null Polymorphism of the NQO1 Gene Contributes Significantly to Breast Cancer Susceptibility in North Indian Populations: a Case Control Study. Asian Pacific Journal of Cancer Prevention. 17(3). 1215–1219. 4 indexed citations
10.
Javid, Jamsheed, et al.. (2016). Involvement of CASP3 promoter polymorphism (−1337 C > G) in the development and progression of non-small cell lung cancer. Tumor Biology. 37(7). 9255–9262. 7 indexed citations
11.
Javid, Jamsheed, et al.. (2015). Extracellular cytochrome c as a biomarker for monitoring therapeutic efficacy and prognosis of non-small cell lung cancer patients. Tumor Biology. 36(6). 4253–4260. 35 indexed citations
12.
Mir, Rashid, Jamsheed Javid, Zahula Mariyam, et al.. (2015). Cell Free EGFR mRNA Expression and Implications for Survival and Metastasis in Non-Small Cell Lung Cancer Cases. Asian Pacific Journal of Cancer Prevention. 16(15). 6445–6449. 8 indexed citations
13.
Mir, Rashid, et al.. (2015). Polymorphism T81C in H-RAS Oncogene Is Associated With Disease Progression in Imatinib (TKI) Treated Chronic Myeloid Leukemia Patients. World Journal of Oncology. 6(2). 321–328. 5 indexed citations
14.
Javid, Jamsheed, Rashid Mir, P.K. Julka, Paramita Ray, & Alpana Saxena. (2015). Role of survivin re-expression in the development and progression of non-small cell lung cancer. Tumor Biology. 36(7). 5543–5550. 9 indexed citations
15.
Javid, Jamsheed, Rashid Mir, Zahula Mariyam, et al.. (2015). Clinical Implication of EGF A61G Polymorphism in the Risk of Non Small Cell Lung Adenocarcinoma Patients: A Case Control Study. Asian Pacific Journal of Cancer Prevention. 16(17). 7529–7534. 7 indexed citations
16.
Javid, Jamsheed, et al.. (2015). Association of p53 and mdm2 in the development and progression of non-small cell lung cancer. Tumor Biology. 36(7). 5425–5432. 17 indexed citations
17.
Mir, Rashid, Jamsheed Javid, Istaq Ahmad, et al.. (2015). Clinical significance of TP53 (R72P) and MDM2 (T309G) polymorphisms in breast cancer patients. Clinical & Translational Oncology. 18(7). 728–734. 10 indexed citations
18.
Javid, Jamsheed, Rashid Mir, Zahula Mariyam, et al.. (2015). Clinical Significance of the NQO1 C609T Polymorphism in Non Small Cell Lung Adenocarcinoma Patients. Asian Pacific Journal of Cancer Prevention. 16(17). 7653–7658. 2 indexed citations
20.
Javid, Jamsheed, Rashid Mir, Zahula Mariyam, et al.. (2014). CC genotype of anti-apoptotic gene BCL-2 (−938 C/A) is an independent prognostic marker of unfavorable clinical outcome in patients with non-small-cell lung cancer. Clinical & Translational Oncology. 17(4). 289–295. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026